Sacral Erector Spinae Plane Block in Normal Birth

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-24

Study Completion Date

2025-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pregnant women feel severe pain during normal birth and in the postpartum period. Preventing pain during and after birth is very important for both the mother and the baby. Rapid recovery in the postoperative period in pregnant women is very important for both mother and baby. To evaluate this recovery, the quality of recovery-10 scores developed by Shalev et al. are used in pregnant women. Our study will be the first in the literature to use sacral erectör spinae plane block (S-ESPB) in normal birth. Our primary aim in this study is to evaluate the effects of S-ESPB on the quality of recovery and recovery at the 24th hour in pregnant women who will undergo vaginal birth with epidural analgesia, using the Quality of Recovery-10T scores.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Trial of Levator Muscle Blocks Following Posterior Colporrhaphy Surgery to Reduce Post-operative Pain.

NCT03067168

Post Operative Pain

UNKNOWN NA

Continuous Erector Spinae Plane Blocks to Treat Postoperative Pain After Open Gynecologic Procedures Via a Low Transverse (Pfannenstiel) Incision

NCT05082155

Surgical Incision Pain, Postoperative Pain, Acute

WITHDRAWN PHASE4

Effect of Local Anesthesia on Postoperative Pain Following Sacrospinous Ligament Fixation

NCT02890199

Pelvic Organ Prolapse

UNKNOWN NA

Regional Analgesia After Cesarean Section

NCT03244540

Cesarean Section Pain, Postoperative Pain, Neuropathic

COMPLETED PHASE4

ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain

NCT03261193

Pain, Postoperative

TERMINATED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pregnant women feel severe pain during normal birth and in the postpartum period. Preventing pain during and after birth is very important for both the mother and the baby. Rapid recovery in the postoperative period in pregnant women is very important for both mother and baby. To evaluate this recovery, the quality of recovery-10 scores developed by Shalev et al. are used in pregnant women. Our study will be the first in the literature to use sacral erectör spinae plane block in normal birth. Our primary aim in this study is to evaluate the effects of sacral erectör spinae plane block on the quality of recovery and recovery at the 24th hour in pregnant women who will undergo vaginal birth with epidural analgesia, using the Quality of recovery-10T score. the numeric rating scale at the 0-15th minute-30th minute-45th minute-1-2-4-8-12-24th hour after the S-ESPB application, and to evaluate the patient satisfaction at the 24th hour with a Likert scale. , the total amount of rescue analgesic ( bupivacaine ) consumed since the application of sacral erectör spinae plane block, the number of pregnant women given oxytocin, the time of the first breastfeeding, complications in the mother (fever, nausea, vomiting, motor block, hip pain), the need for antiemetics, the baby's 1st and 5th minutes. Apgar score at the 1st-2nd-3rd week of birth. is to evaluate the duration of the phases .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SACRAL EREKTÖR SPİNAE PLANE BLOK

Pregnant women in Group S will be given 10 cc bupivacaine solution of 0.25% bupivacaine on both sides.

Group Type ACTIVE_COMPARATOR

% 0.25 bupivakain 20cc

Intervention Type OTHER

Pregnant women in group S will be given 0.25% bupivacaine, 10 cc on each side.

control group

Pregnant women in Group K will be injected with 10 cc of saline on both sides.

Group Type ACTIVE_COMPARATOR

20 cc saline

Intervention Type OTHER

Pregnant women in Group K will be given 10 cc of saline on both sides.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

% 0.25 bupivakain 20cc

Pregnant women in group S will be given 0.25% bupivacaine, 10 cc on each side.

Intervention Type OTHER

20 cc saline

Pregnant women in Group K will be given 10 cc of saline on both sides.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 36-42. Pregnant women who are their gestational age and request epidural anesthesia
* Pregnant women aged 18-42 with ASA II
* Pregnant women who will stay in the hospital for at least 24 hours
* Primiparous pregnant women who will have a planned normal birth
* Singleton births with vertex presentation

Exclusion Criteria

* Pregnant women who do not want to give consent
* Regional anesthesia is contraindicated
* Pregnant women who use anticoagulants and have an abnormal bleeding profile
* Pregnant women with infection in the area to be treated
* Emergency cases and pregnant women who had a birth with instruments (forceps and vacuum)

Minimum Eligible Age

18 Years

Maximum Eligible Age

42 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No